Aruna Bio, Inc. today announced that Dr. Mark A. Sirgo, Chief Executive Officer, will be presenting at the Piper Sandler 33rd Annual Virtual Healthcare Conference.
| ATHENS, Ga. and RESEARCH TRIANGLE PARK, N.C., Nov. 22, 2021 /PRNewswire/ -- ArunA Biomedical, Inc. a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced that Dr. Mark A. Sirgo, Chief Executive Officer, will be presenting at the Piper Sandler 33rd Annual Virtual Healthcare Conference.
The presentation will be webcast and available on the events page of the Aruna Bio website (arunabio.com/events) beginning on November 22, 2021, at 10:00 AM Eastern Time and will be accessible for 90 days after the event. Dr. Sirgo will discuss advances in Aruna Bio’s neural exosome platform and highlight the ability of neural exosomes to deliver a range of therapeutics to the brain and central nervous system to treat neurodegenerative diseases. Dr. Sirgo will also discuss the company’s partnerships as well as the going forward business strategy and key milestones. About Aruna Bio
SOURCE Aruna Bio, Inc. |
View original content to download multimedia:
